Carbon Dot Based Carbon Nanoparticles as Potent Antimicrobial, Antiviral, and Anticancer Agents

Narmin Hamaamin Hussen1, Aso Hameed Hasan2,3, Yar Muhammed FaqiKhedr1

  • 1Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, University of Sulaimani, Sulaimani 46001, Iraq.

ACS Omega
|March 11, 2024
PubMed

Insights

Carbon dots (C-dots) show promise as novel antimicrobial and anticancer agents, offering a low-toxicity alternative to traditional drugs facing increasing microbial resistance. This review explores their structure, synthesis, and therapeutic applications.

Area of Science:

  • Materials Science
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Rising global mortality from infectious diseases and cancer.
  • Increasing microbial resistance to conventional antibiotics.
  • Need for novel therapeutic agents with low toxicity and high efficacy.

Purpose of the Study:

  • To review the structure, classification, and synthesis of carbon dots (C-dots).
  • To explore the antimicrobial applications of C-dots against bacterial, fungal, and viral agents.
  • To examine the anticancer activities of C-dots for therapeutic development.

Main Methods:

  • Review of literature on carbon dot synthesis and characterization.
  • Analysis of studies on C-dot antimicrobial efficacy in vitro and in vivo.
  • Evaluation of research on C-dot anticancer mechanisms and applications.

Main Results:

  • C-dots exhibit low toxicity, good dispersibility, and biocompatibility.
  • C-dots demonstrate significant antibacterial, antifungal, and antiviral properties.
  • C-dots show promising anticancer activity against various cancer cell lines.

Conclusions:

  • Carbon dots are versatile nanomaterials with significant potential in antimicrobial and anticancer therapies.
  • Further research into C-dot functionalization and targeted delivery can enhance their clinical applicability.
  • C-dots represent a promising avenue for developing next-generation therapeutic agents.